Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABUSE COUNSELING AND TREATMENT, INC

UEI: FKLPHE9AK4E3CAGE: 38GJ5

ABUSE COUNSELING AND TREATMENT, INC is a federal contractor, registered under UEI FKLPHE9AK4E3 and CAGE code 38GJ5. It has been awarded $11,019,545 across 38 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Justice (doj), Department Of Health And Human Services (hhs), and Department Of Housing And Urban Development (hud).

Contact Information

Registration and classification details

Registration

UEI Code

FKLPHE9AK4E3

CAGE Code

38GJ5

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

6DA8

NAICS Codes

624221Temporary Shelters(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABUSE COUNSELING AND TREATMENT, INC. specializes in providing comprehensive substance use disorder counseling and behavioral health intervention services, grounded in evidence-based clinical practices. The organization delivers individual and group therapy, crisis intervention, relapse prevention pl...

ABUSE COUNSELING AND TREATMENT, INC. specializes in providing comprehensive substance use disorder counseling and behavioral health intervention services, grounded in evidence-based clinical practices. The organization delivers individual and group therapy, crisis intervention, relapse prevention planning, and trauma-informed care tailored to at-risk populations, including veterans, underserved communities, and individuals referred through social service systems. Their technical expertise includes implementing standardized assessment protocols such as the ASAM Criteria, coordinating with multidisciplinary treatment teams, and integrating case management with mental health and social support services. A key differentiator is their focus on culturally responsive, client-centered care models that emphasize long-term recovery outcomes and community reintegration. Award history is not available to inform specific agency relationships or recent contract activity, so no definitive patterns of engagement with federal or state entities can be confirmed. However, given their NAICS classification under 624221 — Community Mental Health Services — it is inferred that their services align with programs administered by health and human services departments, substance abuse block grant recipients, and possibly corrections or veteran-affiliated behavioral health initiatives. The company operates within the behavioral health and social services vertical, delivering outpatient clinical services that support public health objectives around addiction recovery and prevention. Their market positioning centers on direct-service provision in community-based settings, with an emphasis on accessibility and continuity of care for vulnerable populations. ABUSE COUNSELING AND TREATMENT, INC. is structured as an 8H-certified small business based in Fort Myers, Florida. While no additional federal certifications are listed, their operational model reflects compliance with state-licensed counseling standards and clinical best practices. The organization maintains a localized geographic presence focused on serving Southwest Florida communities, with potential alignment to regional health initiatives and state-funded behavioral health contracts.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Justice (doj)$7.9M71.5%
Department Of Health And Human Services (hhs)$3.0M27.1%
Department Of Housing And Urban Development (hud)$157.6K1.4%
Awards by NAICS
Export
- Unknown NAICS$11.0M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABUSE COUNSELING AND TREATMENT, INC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 493190
Federal
Vehicle Recompete: Idc 15M50022DA4400003This contract is a total small business set-aside with a ceiling value of nearly $3 million, awarded by the U.S. Marshals Service under the Department of Justice. It covers towing, storage, maintenance, and disposal services for seized and/or forfeited vehicles across several districts in the Northeast, specifically Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. The ordering period for this contract extends until late September 2027, although currently, there are no active task orders valued at zero dollars. Key task orders previously issued to RBEX, Inc. indicate substantial past expenditures, with two major task orders valued at over $680,000 and $524,000 respectively. The contract is identified as a recompete, signaling a continuation or replacement of existing services with moderate confidence in the likelihood of award. It is associated with NAICS code 493190, which relates to warehousing and storage services. The solicitation was last posted in March 2026, and it remains a pre-forecast status, suggesting planning stages for future service requirements. The contract specifically supports the logistical and operational needs of vehicle management related to law enforcement activities in the specified districts, emphasizing the critical role of small businesses in fulfilling federal government service contracts in the justice sector.
USMS U.S. Department Of Justice

POSTED

5 months ago

DEADLINE

N/A
View Details
NAICS: 541715
Federal
Vehicle Recompete: Idc 75N95022D00017This contract is an indefinite delivery contract vehicle (IDC) with the identifier 75N95022D00017, overseeing the ordering period from September 5, 2022, through September 4, 2027. It supports the National Institute on Drug Abuse (NIDA) data, statistics, and clinical trial operations under the Department of Health and Human Services, managed by the National Institutes of Health (NIH). The contract has a ceiling value of approximately $44.3 million and does not involve any set-aside provisions. It represents a full recompete classification, indicating a competitive solicitation process to award the contract. Currently, there are no active task orders valued at zero, but several significant task orders have been executed under this vehicle. Several key task orders highlight the contract’s scope and value, all awarded to The Emmes Company, LLC. These task orders cover a variety of research and analytical services, including the management and support of the Data and Statistics Center (DSC) from March 2025 to February 2026 ($1.85 million), data analysis related to GLP-1 as an adjunct to buprenorphine from May 2025 to February 2028 ($1.4 million), and various other clinical and secondary analysis projects concerning opioid use disorder and related research, with task order values ranging from approximately $375,000 to $800,000. The work performed under these task orders reflects a comprehensive support framework for clinical trials and data management activities essential to advancing research efforts around drug abuse and treatment strategies.
National Institutes Of Health Nida

POSTED

6 months ago

DEADLINE

N/A
View Details